YorkBridge Wealth Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$353K Buy
965
+28
+3% +$9.93K 0.09% 156
2022
Q3
$303K Buy
937
+5
+0.5% +$1.58K 0.08% 195
2022
Q2
$302K Hold
932
0.08% 191
2022
Q1
$267K Buy
+932
New +$240K 0.06% 253
2019
Q3
Sell
-639
Closed -$71K 449
2019
Q2
$71K Buy
639
+50
+8% +$5.89K 0.03% 334
2019
Q1
$76K Buy
589
+150
+34% +$18.2K 0.04% 313
2018
Q4
$51K Hold
439
0.03% 332
2018
Q3
$47K Sell
439
-599
-58% -$59.9K 0.02% 363
2018
Q2
$89K Sell
1,038
-140
-12% -$11.5K 0.04% 304
2018
Q1
$93K Sell
1,178
-1,452
-55% -$117K 0.04% 303
2017
Q4
$204K Sell
2,630
-428
-14% -$36.4K 0.1% 174
2017
Q3
$262K Sell
3,058
-141
-4% -$11.6K 0.14% 147
2017
Q2
$265K Buy
3,199
+24
+0.8% +$1.96K 0.14% 141
2017
Q1
$259K Sell
3,175
-82
-3% -$6.57K 0.14% 142
2016
Q4
$225K Buy
+3,257
New +$243K 0.13% 147

Other funds holding LLY

YorkBridge Wealth Partners's LLY Position: Q4 2022 in Review

YorkBridge Wealth Partners increased its Eli Lilly (LLY) stake by 3% in Q4 2022, buying an estimated $9.93K and bringing the position to 965 shares worth $353K. The position accounts for 0.09% of the portfolio, ranked #156.

YorkBridge Wealth Partners first reported a position in LLY in Q4 2016 and has held it in 15 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.

  • YorkBridge Wealth Partners held 965 shares of Eli Lilly worth $353K as of Q4 2022.
  • YorkBridge Wealth Partners bought 28 Eli Lilly shares in Q4 2022, an estimated $9.93K.
  • Eli Lilly made up 0.09% of YorkBridge Wealth Partners's portfolio in Q4 2022, its #156 holding.
  • YorkBridge Wealth Partners first reported a position in Eli Lilly in Q4 2016 and has held it in 15 quarters since.
  • 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.

Based on YorkBridge Wealth Partners's 13F filing for Q4 2022, filed 26 Jan 2023.